DOC 2026 will take place this October in Sonoma, and the program is now live.
If you are involved professionally or personally with the future of healthcare, medicine, or longevity — and looking to join a community of the intellectually curious who want to redefine how we age and how medicine is practiced — DOC should be on your radar.
The next decade of health span will be shaped at the intersection of neuroscience, longevity science, medical AI, genetics, diagnostics, and behavioral change. More importantly, it will be defined by whether those fields can move beyond hype and toward real clinical impact. That’s the premise of DOC: to bring together scientists, physicians, founders, investors, and policymakers working on the systems, therapies, and technologies that are moving the longevity field forward.
The magic of DOC isn’t in its headliners or its location, though both are fabulous. It’s in the care we take in assembling the people who gather each year. Among the 300 members are the field’s leading voices who all share a passion for identifying, scaling, and supporting the highest-quality science behind the medical breakthroughs that can effect meaningful change, right now. They all are accustomed to keynoting conferences and events around the world.
That’s why we consider each DOC program a conversation, not a dictation – and why every participant may interrogate the proceedings at any time with questions or insights that add to that conversation.
This year’s program focuses on topics and issues at the forefront of our community’s minds: The impact of AI on medicine. The state of our healthcare system. Breakthroughs in neuroscience that push the boundaries between our brains and the emerging intelligence of artificial intelligence. Advances in women’s health.
Among the leaders joining us from government, science, business, and finance are:
Alicia Jackson, Ph.D., Director of ARPA-H. Dr. Jackson is responsible for determining where her agency will place billions of dollars in long-term bets on the future state of medical science.
Edward Chang, M.D., Chair of Neurological Surgery at the University of California, San Francisco, whose pioneering work on brain-computer interfaces is redefining the field.
Laura Esserman, M.D., MBA, Principal Investigator of the WISDOM Study and Director of the UCSF Carol Franc Buck Breast Care Center, who will report on the initial findings from her groundbreaking research on breast cancer detection and risk reduction.
Travis Zack M.D., Ph.D., Chief Medical Officer, OpenEvidence. Zack is the medical mind responsible for the astonishing rise of OpenEvidence, one of the fastest growing and most respected AI companies in the world.
Helen Messier M.D., Ph.D., Chief Medical Officer of Bioscope.AI. Dr. Messier is a physician-scientist and leader in precision and longevity medicine, working at the intersection of molecular biology, clinical care, and new models of care delivery.
Larry Brilliant, M.D., a renowned epidemiologist, technologist, philanthropist, and author, now CEO of Evity.AI, a startup integrating artificial intelligence with epidemiology and precision medicine.
Nicole Gaudelli, Ph.D., a life science entrepreneur in residence at Google Ventures best known for her work in creating the Adenine Base Editor, a significant advance on the CRISPR gene-editing framework.
George Yancopoulos, M.D., Ph.D., Co-founder, Board co-Chair, President and Chief Scientific Officer, Regeneron. Dr. Yancopoulos is widely recognized as one of the most successful entrepreneurs, scientists and drug discoverers in biotech history.
Divesh Makan, General Partner, Iconiq Capital. Makan is credited with being one of the tech elite’s most trusted investors, and is one of the most savvy and influential investors in the artificial intelligence industry.
And that’s not even half of the extraordinary leaders that will join us for the extended conversation this year at DOC.
We’re extremely proud of the community we’re building. If you’re interested in joining us at the third annual DOC summit, please let us know — we can’t wait to see you there.